Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Скринер
Новости
О нас

AXGN - Axogen, Inc. Последние новости | Finranks

Home

/

AXGN

A

Axogen, Inc. (AXGN)

NCM – Цена в реальном времени. Валюта: USD

40.93

+0.14 (0.34%)

При закрытии: May 12, 2026, 4:00 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

ALACHUA, Fla. and TAMPA, Fla.

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

AxoGen (AXGN) Q1 Earnings Lag Estimates

AxoGen (AXGN) Q1 Earnings Lag Estimates

AxoGen (AXGN) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.12 per share. This compares to a loss of $0.02 per share a year ago.

Axogen, Inc. Reports First Quarter 2026 Financial Results

Axogen, Inc. Reports First Quarter 2026 Financial Results

ALACHUA, Fla. and TAMPA, Fla.

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth

AxoGen (AXGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?

AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?

AxoGen (AXGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026

Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026

ALACHUA, Fla. and TAMPA, Fla.

Видео

No Data

There is no data to display

Пресс-релизы

Axogen, Inc. Reports First Quarter 2026 Financial Results

Axogen, Inc. Reports First Quarter 2026 Financial Results

ALACHUA, Fla. and TAMPA, Fla.

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

22.01.2026

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

ALACHUA, Fla. and TAMPA, Fla.

Axogen Announces Proposed Public Offering of Common Stock

Axogen Announces Proposed Public Offering of Common Stock

ALACHUA, Fla. and TAMPA, Fla.

Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025

Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025

ALACHUA, Fla. and TAMPA, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced preliminary unaudited fourth quarter and full-year 2025 key financials.